Clinical Trial: Tirzepatide for the Treatment of Cannabis Use Disorder

U.S., Dec. 6 -- ClinicalTrials.gov registry received information related to the study (NCT07265752) titled 'Tirzepatide for the Treatment of Cannabis Use Disorder' on Nov. 25.

Brief Summary: This is a pilot randomized cross-over trial to examine the effects of tirzepatide on cue-reactivity among individuals with cannabis use disorder.

Study Start Date: July 01, 2026

Study Type: INTERVENTIONAL

Condition: Cannabis Use Disorder

Intervention: DRUG: Tirzepatide

2.5mg SC injection once

DRUG: Placebo

Saline placebo injection once

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Brigham and Women's Hospital

Information provided by (Responsible Party): Joji Suzuki, MD, Brigham and Women's Hospital

Published by HT Digital Content Service...